MHI
CPRX icon

Miller Howard Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

Miller Howard Investments’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32,439
Closed -$545K – 196
2023
Q4 		$545K Buy
32,439
+395
+1% +$5.4K 0.02% 149
2023
Q3 		$375K Sell
32,044
-58
-0.2% -$776 0.01% 155
2023
Q2 		$431K Buy
32,102
+206
+0.6% +$2.96K 0.02% 158
2023
Q1 		$529K Buy
31,896
+333
+1% +$5.49K 0.02% 147
2022
Q4 		$587K Buy
31,563
+4
+0% +$62 0.02% 145
2022
Q3 		$405K Buy
31,559
+74
+0.2% +$877 0.02% 156
2022
Q2 		$221K Buy
+31,485
New +$231K 0.01% 185

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Miller Howard Investments's CPRX Position: Q1 2024 in Review

Miller Howard Investments sold out of Catalyst Pharmaceutical (CPRX) in Q1 2024, closing a stake of 32,439 shares — an estimated $545K sold.

Miller Howard Investments first reported a position in CPRX in Q2 2022 and held it in 7 quarters. The position peaked at $587K in Q4 2022. 269 funds tracked by Wall St. Rank hold CPRX as of Q1 2024.

  • Miller Howard Investments reported no remaining Catalyst Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Miller Howard Investments sold 32,439 Catalyst Pharmaceutical shares in Q1 2024, an estimated $545K.
  • Miller Howard Investments first reported a position in Catalyst Pharmaceutical in Q2 2022 and held it in 7 quarters.
  • Miller Howard Investments's Catalyst Pharmaceutical position peaked at $587K in Q4 2022.
  • 269 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2024.

Based on Miller Howard Investments's 13F filing for Q1 2024, filed 12 Apr 2024.